Published Date: 10 Mar 2023
According to a new study published in BMC Anesthesiology, the use of non-opioid anesthesia (OFA) is similar to opioid-based anesthesia (OA)...
Read Full NewsChronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 200,000 people in the United States.
Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast cancer, according to new results presented at the Advanced Breast Cancer Eighth International Consensus ...
1.
Distinct results for patients with positive and negative pancreatic cancer who are treated with systemic therapy, chemotherapy, and radiation.
2.
From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
3.
Potentially Novel Approach for Treating Advanced Colorectal Cancer with KRAS Mutations.
4.
GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients.
5.
Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments
1.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
2.
Future of Oncology: Targeted Therapies & Collaborative Innovation Shaping Cancer Care in the USA
3.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
4.
The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment
5.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation